In HBV-positive HCC patients, the survival rate of patients with high expression of GPC3 was significantly lower than that of patients with low or no expression of GPC3; and the expression of GPC3 was positively correlated with poor tumor differentiation, portal vein tumor thrombus and tumor lymphatic metastasis 69. The gene discussed is GPC3; the disease is neoplasm.